MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BDSX — Biodesix, Inc. Common Stock

Nasdaq

Biodesix, Inc. Common Stock

Back to Screener
$27.72
+0.39(+1.43%)
O
27.55
H
28.72
L
26.97
V
124.14K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About BDSX

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateOct 28, 2020
Employees334
Stock ExchangeNasdaq
Ticker SymbolBDSX

Key Financial Statistics

Market Cap$307.04M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$5.26 - $31.97
52-Week Avg Volume435.8K
VWAP$28.15
Transactions3,519
Total Recorded Bars1,489 days